文献速递关节外科

70岁及以上患者全髋关节置换术中非骨水泥与骨水泥股骨柄的比较

Cementless Versus Cemented Stems in Patients Aged 70 Years or Older Undergoing Total Hip Arthroplasty.
PubMed 文献 · J Arthroplasty · 2025-02-17

这项回顾性研究纳入2007年1月1日至2019年10月1日期间接受初次全髋关节置换术的70岁及以上患者共2136例(骨水泥组355例,非骨水泥组1781例),比较两组假体生存率、翻修原因及患者报告结局。非骨水泥组与骨水泥组在5年和10年全因、无菌性及无菌性股骨柄翻修的累积生存率上均无差异,末次随访时各项患者报告结局评分变化值也无差异。作者结论认为,对于70岁及以上接受择期全髋关节置换术的患者,非骨水泥与骨水泥股骨柄在生存率上无差异,两者均为安全有效的选择。

要点

  • 非骨水泥组与骨水泥组5年和10年全因翻修累积生存率无差异(P=0.11)。
  • 两组无菌性翻修(P=0.83)及无菌性股骨柄翻修(P=0.61)累积生存率均无差异。
  • 末次随访时两组WOMAC、VR12心理、VR12躯体及Harris髋关节评分变化值均无差异。

核心结论

  • 对于70岁及以上接受择期全髋关节置换术的患者,非骨水泥与骨水泥股骨柄在全因及无菌性翻修生存率上无差异。
  • 非骨水泥与骨水泥股骨柄均为老年患者行全髋关节置换术的安全有效选择。

研究设计与样本

  • 回顾性研究,纳入2007年1月1日至2019年10月1日期间接受初次全髋关节置换术的70岁及以上患者共2136例,其中骨水泥组355例、非骨水泥组1781例。
  • 非骨水泥组与骨水泥组人口学特征分别为:年龄77岁对83岁、体重指数29对26、女性比例59%对83%。
  • 采用Kaplan-Meier法计算以全因翻修、无菌性翻修及无菌性股骨柄翻修为终点的假体生存率,变化值比较采用独立t检验。

主要发现

  • 非骨水泥组与骨水泥组5年和10年全因翻修累积生存率无差异(P=0.11),无菌性翻修无差异(P=0.83),无菌性股骨柄翻修无差异(P=0.61)。
  • 非骨水泥组与骨水泥组全因翻修长期生存率分别为96.8%与95.5%,无菌性翻修分别为97.8%与98.3%,无菌性股骨柄翻修分别为98.4%与98.3%。
  • 末次随访时非骨水泥组与骨水泥组WOMAC评分变化值分别为33.9与35.3(P=0.48),VR12心理评分变化值分别为0.56与1.42(P=0.58),VR12躯体评分变化值分别为8.9与8.0(P=0.21),Harris髋关节评分变化值分别为43.1与44.9(P=0.25),均无差异。

临床怎么用

  • 作者结论认为,对于70岁及以上接受择期全髋关节置换术的患者,非骨水泥与骨水泥股骨柄均为安全有效的选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Controversy exists regarding the most appropriate femoral implant selection in older patients undergoing total hip arthroplasty (THA). Our study aimed to compare the survivorship, reasons for revision, and patient-reported outcome measures of uncemented versus cemented THA in patients aged ≥ 70 years. METHODS: This retrospective study reviewed primary THAs performed on patients aged ≥ 70 years between January 1, 2007, and October 1, 2019. A total of 2,136 patients [cemented (n = 355), cementless (n = 1,781)] were included. Demographics including age in years (77 versus 83), body mass index (29 versus 26), and sex (59 versus 83% women) were different between the cementless and cemented THA cohorts, respectively. Patient characteristics, implant characteristics, revision information, mortality, and patient-reported outcome measures [Western Ontario and McMaster University Osteoarthritis Index, Veterans Rand 12 Item Health Survey (VR12), and the Harris Hip Score were collected. Kaplan-Meier survivorship was performed with all-cause, aseptic, and aseptic stem revisions as the endpoint. Change scores were calculated and compared with independent t-tests. RESULTS: There were no differences in the 5- and 10-year cumulative survival in the cementless and cemented THA cohorts for all-cause (P = 0.11), aseptic (P = 0.83), and aseptic stem revisions (P = 0.61). Both cohorts demonstrated excellent long-term survival for all-cause (96.8 versus 95.5), aseptic (97.8 versus 98.3), and aseptic stem (98.4 versus 98.3) revisions. There were no differences in change scores for Western Ontario and McMaster University Osteoarthritis Index (33.9 versus 35.3, P = 0.48), VR12 mental (0.56 versus 1.42, P = 0.58), VR12 physical (8.9 versus 8.0, P = 0.21), and Harris Hip (43.1 versus 44.9, P = 0.25) scores between the cementless and cemented cohorts at the latest follow-up. CONCLUSIONS: No difference was found in survival rates of cementless compared to cemented stems for all causes and aseptic causes in patients aged ≥ 70 years undergoing elective THA. Both cementless and cemented femoral stems provide a safe and efficacious option for performing THA in older patients.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Rocha AC, Somerville LE, Moody PW, et al. Cementless Versus Cemented Stems in Patients Aged 70 Years or Older Undergoing Total Hip Arthroplasty. J Arthroplasty. 2025. PMID: 39971208. doi:10.1016/j.arth.2025.02.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。